Physician profile
Michael Drake
NPI 1093332728
$1,864.32
in general payments reported to CMS, 2019-2025
8 companies · $1,259 in 2025
The $1,259 reported for 2025 was more than what 97% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $79.58 · 2022: $124 · 2023: $293 · 2024: $108 · 2025: $1,259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Entertainment: $915 · Food and Beverage: $733 · Education: $12.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Entertainment | $914.62 |
| Food and Beverage | $732.80 |
| Education | $12.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $1,326.95 | 2022-2025 | |
| Nobel Biocare USA | $308.80 | 2021-2023 | Nobelactive |
| Align Technology, INC. | $76.36 | 2021-2024 | Invisalign |
| Biohorizons Implant Systems INC. | $53.08 | 2023-2025 | Biohorizons, Biohorizons Dental Implants, Biohorizons Dental Prosthetics |
| Envista Holdings Corporation | $31.95 | 2025 | Tf Adaptive |
| Dentsply Sirona INC | $27.69 | 2022-2023 | Trushape Gutta-Percha 40/06v |
| Gc America INC. | $25.06 | 2021-2023 | G-Aenial |
| Colgate Oral Pharmaceuticals, INC. | $14.43 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Drake listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.